glp 1 controversy FDA says that the GLP-1 shortage is over GLP-1 Genetics: How Genes Affect

others can gain novel biological activities and thereby contribute to the various pathophysiological processes

Keshri, P

Early results suggested that the peptide might have contributed to an increase in body mass and possibly raised the bone mineral content (BMC) in the tibia and vertebrae, as indicated by DEXA measurements, compared to the control group

Even in India, early access to innovator brands like Novo Nordisk Ozempic and Wegovy (both semaglutide), plus Rybelsus, Victoza, and Trulicity, meant bills of 10,00020,000 per month for many patients, putting these drugs out of reach for the average middle-class household